Susquehanna Portfolio Strategies’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$810K Buy
82,710
+14,840
+22% +$147K 0.01% 589
2026
Q1
$660K Buy
67,870
+9,017
+15% +$82.6K 0.01% 709
2025
Q4
$562K Buy
58,853
+29,878
+103% +$304K 0.01% 760
2025
Q3
$283K Sell
28,975
-42,693
-60% -$328K ﹤0.01% 923
2025
Q2
$435K Buy
+71,668
New +$538K 0.01% 688
2024
Q1
Sell
-20,158
Closed -$733K 917
2023
Q4
$733K Buy
+20,158
New +$776K 0.01% 672

Other funds holding PRTA

Susquehanna Portfolio Strategies's PRTA Position: Q2 2026 in Review

Susquehanna Portfolio Strategies increased its Prothena Corp (PRTA) stake by 22% in Q2 2026, buying an estimated $147K and bringing the position to 82,710 shares worth $810K. The position accounts for 0.01% of the portfolio, ranked #589.

Susquehanna Portfolio Strategies first reported a position in PRTA in Q4 2023 and has held it in 6 quarters since. 188 funds tracked by Wall St. Rank hold PRTA as of Q2 2026.

  • Susquehanna Portfolio Strategies held 82,710 shares of Prothena Corp worth $810K as of Q2 2026.
  • Susquehanna Portfolio Strategies bought 14,840 Prothena Corp shares in Q2 2026, an estimated $147K.
  • Prothena Corp made up 0.01% of Susquehanna Portfolio Strategies's portfolio in Q2 2026, its #589 holding.
  • Susquehanna Portfolio Strategies first reported a position in Prothena Corp in Q4 2023 and has held it in 6 quarters since.
  • 188 funds tracked by Wall St. Rank held Prothena Corp as of Q2 2026.

Based on Susquehanna Portfolio Strategies's 13F filing for Q2 2026, filed 14 Aug 2026.